Interesting for those suffering from IBS etc. @CellPressNews@Nature
Chronic stress can inflame the gut — now scientists know why https://t.co/g3rJBV3EsG
Lithuanian company Droplet Genomics presented their technology at @imperialcollege yesterday. A very promising single cell microfluidics company! #singlecell#dropletgenomics
In 2015, an article in @nature estimated that 800,000,000 USD is wasted annually on nonspecific antibodies.
It also suggested standardization, which has not happened. I wonder how much we will spend in 2023 on low specificity antibodies.
We are HIRING! Two Research Technician positions are available in the EROGLU LAB!!! Come work with us on the most amazing cells in the brain, the ASTROCYTES!
https://t.co/NItqlKXwou
https://t.co/V5KWtb5jaE
We are HIRING! Two Research Technician positions are available in the EROGLU LAB!!! Come work with us on the most amazing cells in the brain, the ASTROCYTES!
https://t.co/NItqlKXwou
https://t.co/V5KWtb5jaE
@ucl now has technical staff twitter account @TechsatUCL. This week they are highlighting how they support development of technical staff. Keep an eye, techs!
This is it! Tomorrow is your last chance to register for #FoG2023 - the UK's largest genomics event!
Online registration ends at 23:59 Tuesday 24th January, so don't miss out on the opportunity to learn, network and be inspired. Register now at https://t.co/XtD4njH3HU #genomics
Please, RT
We’re looking for a Research #technician to join our #neuroscience lab.
Join our international and cool group to study how animals make decisions when faced with conflicting situations.
Apply and find more info here: https://t.co/rMMLnuHUUH
Closing Date: 05/02/23
There are 20,000 protein-coding genes in the human genome, but nearly 150,000 transcripts. Explore the biological significance of transcript isoforms and how our long-read sequencing protocols for #singlecell and #visiumspatial can help you detect them. https://t.co/P8CCCDJ7AU
It's finally here!! Our Method of the Year 2022 is....long-read sequencing! 🎉
Read our (free!) Editorial to learn why we felt the time was right to select this class of powerful technologies as the Method of the Year.
https://t.co/shnaRqYIxx
Exciting news today as results from phase 3 trial of #Alzheimers drug lecanemab presented at #CTAD22 confirm the drug reduced amyloid in the brain & slowed cognitive decline👏
UK DRI researchers comment on the news, hailed as 'the beginning of the end'🙌👉https://t.co/8YZMSrdVuO
Can we analyze millions of single-cell proteomes?
Can we achieve high accuracy & low cost?
This @NatureBiotech article https://t.co/Lkf108NwPJ outlines a path forward.
The principle was demonstrated by @slavovLab https://t.co/DZ0E7vC6lR